Search Results
Site Search
Mayo Clinic Laboratory and Pathology Research Roundup: January 9 - Insights
inflammatory disease, on treatment with daily subcutaneous injections of 600 mg of recombinant interleukin-1 receptor antagonist (IL-1Ra) protein, anakinra, since the age of 28, who presented with golf-ball size...
ISO15189 Accredited Certificate NEW 2024 PDF Ver.psmd
The organization named above is granted this accreditation in accordance with the recognized International Standard ISO 15189:2012, Medical Laboratories – Requirements for quality and competence. This accreditation demonstrates competence...
Mayo Clinic Laboratory and Pathology Research Roundup: January 23 - Insights
administered in recurrent GBM patients either at the resection cavity (Group A), or, intratumorally on day 1, followed by a second dose administered in the resection cavity after tumor resection on day 5 (Group...
MCL Inborn Errors Immunity Autoimmunity Autoinflammatory Disease Patient Information Complete print Reset Form Inborn Errors Immunity Autoimmunity Autoinflammatory Disease Patient Information Instructions Accurate interpretation reporting
autoimmune-paraneoplastic-movement-disorder-evaluation-algorithm-serum.pdf
© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 05/2024 Autoimmune/Paraneoplastic Movement Disorder Evaluation Algorithm – Serum ■ GFAP alpha subunit antibody by CBA ■ GFAP alpha subunit antibody by...
newborn-screen-elevated-c0-c16-c18.pdf
© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 08/20/23 Newborn screen results: ■ Elevated or normal free carnitine (C0) ■ Elevated C0/C16+C18 ratio Perform: Plasma ammonia, blood gas, glucose,...
MCL Coagulation Test Request Form T753 MC076704A
MCL Coagulation Test Request Form T753 Complete print Reset Form Coagulation Test Request Client Information required Client Patient Information required Patient ID Medical Record
MCL Combined Immunodeficiency Severe Combined Immunodeficiency BCellAntibody Deficiency Patient Information Complete print Reset Form Combined Immunodeficiency Severe Combined Immunodeficiency Cell Antibody Deficiency Patient Information...
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) calculator - Insights
For guidance on when to use the calculator, please see the following algorithm: Acquired Neuropathy Diagnostic Algorithm.
New tests launched in May - Insights
In May 2022, Mayo Clinic Laboratories announced multiple new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
MCL - Blood Spot Collection Instructions (Spanish) - Brochure - MC4091-67SP
MCL - Blood Spot Collection Instructions (Spanish) - Brochure
Mayo Clinic Laboratories Critical Values / Critical Results List
Mayo Clinic Laboratories Critical Values / Critical Results List DEFINITION A Critical Value / Critical Result is defined as: A value/result that represents a pathophysiological state at such variance with normal (expected values) as...
Pleural Mesothelioma - Insights
In this month's "Hot Topic," Anja Roden, M.D., a thoracic pathologist at Mayo Clinic, gives an update on the 2021 World Health Organization (WHO) classification and ancillary testing of pleural mesothelioma.
Whole exome sequencing for hereditary disorders - Insights
Cherisse Marcou, Ph.D., and Marissa Ellingson, M.S., CGC, discuss whole exome sequencing (WES) at Mayo Clinic Laboratories. The comprehensive evaluation uses next-generation sequencing to detect for single nucleotide variants, small...
New Tests Launched in February - Insights
In February 2020, Mayo Clinic Laboratories announced one new test along with numerous reference value changes, obsolete tests, and algorithm changes.
MayoACCESS® Workstation Setup Guide Page 2 4/28/25 MayoACCESS Workstation Setup Guide TABLE OF CONTENTS Introduction...
Sudden cardiac death and episodes of fainting and seizures from long QT syndrome are significantly lower than previously thought when patients are diagnosed and treated at a specialty center dedicated to the treatment of genetic heart...
Biomarker and companion diagnostic testing - Insights
Browse our suite of diagnostic, therapeutic and prognostic, quantitative and semi-quantitative immunohistochemical stains with interpretation.
Biomarker and companion diagnostic testing - Insights
Browse our suite of diagnostic, therapeutic and prognostic, quantitative and semi-quantitative immunohistochemical stains with interpretation.
Biomarker and companion diagnostic testing - Insights
Browse our suite of diagnostic, therapeutic and prognostic, quantitative and semi-quantitative immunohistochemical stains with interpretation.
Biomarker and companion diagnostic testing - Insights
Browse our suite of diagnostic, therapeutic and prognostic, quantitative and semi-quantitative immunohistochemical stains with interpretation.
Biomarker and companion diagnostic testing - Insights
Browse our suite of diagnostic, therapeutic and prognostic, quantitative and semi-quantitative immunohistochemical stains with interpretation.
Biomarker and companion diagnostic testing - Insights
Browse our suite of diagnostic, therapeutic and prognostic, quantitative and semi-quantitative immunohistochemical stains with interpretation.
Biomarker and companion diagnostic testing - Insights
Browse our suite of diagnostic, therapeutic and prognostic, quantitative and semi-quantitative immunohistochemical stains with interpretation.
IDH assay facilitates timelier leukemia treatment: Rong He, M.D. - Insights
In this test-specific episode of the "Answers From the Lab" podcast, Rong He, M.D., explains how Mayo Clinic Laboratories' IDHQ test improves upon next generation sequencing for assessing AML treatment options.
Psychotropic PGx Panel for Drug Treatment Optimization [Test in Focus] - Insights
Ann Moyer, M.D., Ph.D. gives an overview of this new test available through Mayo Clinic Laboratories. She discusses when this testing should be ordered, how this testing improves upon other testing approaches, and what clinical action can...
Applying the Staffing-to-Workload Methodology: Same-Day Testing Staffing Model - Insights
Mike Baisch, Principal Systems Engineer at Mayo Clinic, discusses how to apply the staffing-to-workload methodology to accommodate same-day testing requirements.
critical-values-semi-urgent-results-list.pdf
PURPOSE DEFINITON Test Report Name Age Critical Low Critical High Units Activated Partial Thromboplastin Time, Plasma Any – ≥ 150 sec Fibrinogen Any ≤ 60 – mg/dL 0 – 7 weeks ≤ 6.0 ≥ 24.0 g/dL > 7 weeks ≤ 6.0 ≥ 20.0 g/dL INR (International...
Find out more about UBA1Q, a quantitative droplet digital polymerase chain reaction (ddPCR) assay that targets seven possible mutations that can occur in the UBA1 gene and help identify VEXAS syndrome.
Emergency/Overdose - Mayo Clinic Laboratories
Emergency/Overdose This test is intended to manage an apparent overdose, intoxicated patient, or determine if a specific set of symptoms might be due to the presence of drugs. This test is designed...
Mayo Clinic Laboratory and Pathology Research Roundup: November 7, 2023 - Insights
This week's research roundup feature: Cytomegalovirus (CMV) is a significant cause of morbidity and mortality among immunocompromised hosts, including transplant recipients. Antiviral prophylaxis or treatment is used to reduce the incidence...
Applying the Staffing-to-Workload Methodology: Identifying Daily Indirect Effort Needs - Insights
Mike Baisch, Principal Systems Engineer at Mayo Clinic, demonstrates how daily indirect effort tasks contribute to staffing plans and needs in the staffing-to-workload methodology.
New tests launched in March - Insights
In March 2022, Mayo Clinic Laboratories announced eighteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
https://news.mayocliniclabs.com/file-mfa-user-guide/
Multi-Factor Authentication for Mayo Clinic Laboratories Applications User’s Guide Page 2 10/10/2023 Multi-Factor Authentication User’s Guide TABLE OF CONTENTS Introduction...
TPNUQ genotyping assay - Insights
Ann Moyer, M.D., Ph.D., discusses TPNUQ, Mayo Clinic Laboratories' genotyping test for identifying patients at risk for thiopurine toxicity. Used prior to therapy initiation, our assay evaluates for nuances in both TPMT and NUDT15, which...
Calprotectin and Inflammatory Bowel Disease - Insights
The differential diagnosis for inflammatory bowel disease (IBD) includes irritable bowel syndrome (IBS). While the clinical presentation is similar, IBD is an inflammatory disease, while IBS is a noninflammatory disease. View this "Hot...
Multi-Factor Authentication for Mayo Clinic Laboratories Applications User’s Guide Page 2 6/27/2024 Multi-Factor Authentication User’s Guide TABLE OF CONTENTS Introduction...
COVID-19 weekly news: April 4-10 2022 - Insights
Topic's Include: Testing wastewater for COVID-19: The clearest path to understanding community infection, and the latest advice about COVID-19 boosters.
October 2023 - Gynecological Pathology and Surgical Pathology - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case’s sub-specialties are Gynecological Pathology and Surgical Pathology.
FDA-approved test expands options for Alzheimer's disease - Insights
Joshua Bornhorst, Ph.D., describes the new, FDA-approved Alzheimer's disease (AD) test and how it differs from Mayo Clinic Laboratories' existing AD evaluation. The laboratory will offer both tests, to ensure flexibility and options for...
© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. AATHR / Thrombophilia Profile, Plasma and Whole Blood Testing begins with: ■ Prothrombin Time (PT), Plasma ■ Activated Partial Thromboplastin Time (APTT),...
MCLRequest for Supplies MC0748
MCLRequest Supplies Complete print Request Supplies Reset Form Client Information required Client Account Number Client Contact Phone Date
MCL Pricing Custom Gene Ordering MC4091141
MCL Pricing Custom Gene Ordering Custom Gene Panel Ordering Pricing Tiers CGPH Custom Gene Panel Hereditary Generation Sequencing NGS Varies Explanation Pricing
MCL Pricing Custom Gene Ordering MC4091141
MCL Pricing Custom Gene Ordering Custom Gene Panel Ordering Pricing Tiers CGPH Custom Gene Panel Hereditary Generation Sequencing NGS Varies Explanation Pricing
Testing Archives - Page 3 of 26 - Insights
Skip to Content MayoACCESS MayoLINK Register My Dashboard...
Focused Pharmacogenomics Panel [Test in Focus] - Insights
Ann Moyer, M.D., Ph.D., explains Mayo Clinic Labs’ new focused pharmacogenomics panel, a real-time, PCR-based testing approach that assesses 10 genes known for their drug-gene associations, to provide guidance on medication selection for...
CNS Demyelinating Disease Testing - Mayo Clinic Laboratories
We offer the only FACS assay for CNS Demyelinating Disease. Our testing ensures the highest senstivity and specificity, providing the most accurate results for patients.
In this month’s “Hot Topic,” Robin Patel, M.D., discusses the FilmArray meningitis/encephalitis (ME) panel, describing the panel, her experience with it, and an algorithm for its use.
The diagnosis of Myeloproliferative Neoplasm (MPN) must include an integrated approach and combine the clinical findings with laboratory results. In our latest “Hot Topic,” Rong He, M.D., discusses the subclassification of MPNs and the use...
Frequently asked questions - Insights
Read answers to frequently asked questions about prenatal testing at Mayo Clinic Laboratories, including specimen requirements, maternal cell contamination testing, pricing, and more.